Among these factors, higher LDH, IGFBP 1 gene expression and IGFBP 1 level were found to be significant predictors of resistance to TKIs treatment in studied CML cases. The gene discussed is IGFBP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.